Company: NIVFW
Filing Date: 2025-05-15
Form Type: 20-F/A
Source: 0001213900-25-043940
Chunk: 5

Company: NewGenIvf Group Ltd
Filing Date: 2025-05-15
Form: 20-F/A
Chunk 5
---
, 2025 |
| Ho Fai Chung             |     | -Principal Financial Officer and Principal Accounting Officer |     |              |

3 NEWGENIVF GROUP LIMITED

| AUDITED CONSOLIDATED FINANCIAL STATEMENTS                                                                                  |     |     |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 6732)                                                   |     | F-2 |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 6743)                                                   |     | F-3 |
| Consolidated Balance Sheets as of December 31, 2024 and 2023                                                               |     | F-4 |
| Consolidated Statements of Operations and Comprehensive Income (Loss) for the Years Ended December 31, 2024, 2023 and 2022 |     | F-5 |
| Consolidated Statements of Changes in Shareholders’ Equity (Deficit) for the Years Ended December 31, 2024, 2023 and 2022  |     | F-6 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023 and 2022                                 |     | F-7 |
| Notes to the Consolidated Financial Statements                                                                             |     | F-8 |

F-1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

| To: | The Board of Directors and Shareholders of NewgenIvf Limited |

Opinion on the Financial Statements We have audited the accompanying consolidated balance sheet of NewgenIvf Limited and its subsidiaries (collectively, the “Company”) as of December 31, 2023, the related consolidated statements of operations and comprehensive income, shareholders’ equity, and cash flows for the year ended December 31, 2023, and the related notes to the consolidated financial statements and schedule (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its operations and its cash flows for the year ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America. Material Uncertainty relating to Going Concern The accompany financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company had bank balance of $54,104 as of December 31, 2023 and for the year ended